🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety, tolerability, PK, and PD of a once weekl...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00770159
Treatments Being Tested
This study will evaluate the therapeutic effects and safety of odanacatib o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01552122
This study will assess the safety, tolerability, pharmacokinetics, and phar...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00769418
Treatments Being Tested
This is a 4-week study to examine the effects of a new experimental medicat...
Status
Completed
Location
Multiple Locations
Start Date
2006-11-16
Trial ID
NCT00399802
Treatments Being Tested
This study will test the weighted average inhibition of u-NTx/Cre (aminoter...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-08
Trial ID
NCT01068262
Treatments Being Tested
The purpose of the event-driven base study is to determine the safety and e...
Status
Terminated
Location
Multiple Locations
Start Date
2007-09-13
Trial ID
NCT00529373
Treatments Being Tested
This study will evaluate the safety and treatment effect of 50 mg odanacati...
Status
Completed
Location
Multiple Locations
Start Date
2008-10-02
Trial ID
NCT00729183
Treatments Being Tested
The purpose of this study is to test the hypothesis that treatment with oda...
Status
Completed
Location
Multiple Locations
Start Date
2010-06-09
Trial ID
NCT01120600
Treatments Being Tested
The study will evaluate the both the efficacy of odanacatib on Bone Mineral...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-13
Trial ID
NCT00885170
Treatments Being Tested
The purpose of this study is to investigate the effects of MK0822 in prolon...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00691899
Treatments Being Tested